Myotonic dystrophy type 1 gene therapy (Kate Therapeutics)

N/A

Report date: 2025/03/20 15:25:56

Base Information

Drug NameMyotonic dystrophy type 1 gene therapy (Kate Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionMyotonin-protein kinase modulators
TargetsMyotonin-protein kinase
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKate Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKate Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A